VENATORX PHARMACEUTICALS INC

Maintenance mode | Venatorx Pharmaceuticals

Malvern, United States · Founded 2015 · $72.6M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$72.6M
Last Round
$2.0M GrantApr 2024
Rounds
17

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

VenatoRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel anti-infectives to combat multi-drug-resistant bacterial infections. Their lead program, cefepime-taniborbactam, is a beta-lactam/beta-lactamase inhibitor combination targeting carbapenem-resistant pathogens causing urinary tract infections and hospital-acquired pneumonia. The company has filed over 100 patents and received multiple BARDA contracts.

Summary

VENATORX PHARMACEUTICALS INC is a Biotech company based in Malvern, United States, founded in 2015. It has raised $72.6M in total across 17 rounds, most recently a $2.0M Grant round in Apr 2024. Investors include AMR Action Fund and Abingworth Bioventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Apr 2024
$2.0M

Sign up to see all 17 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

VENATORX PHARMACEUTICALS INC on Indexed.vc
<a href="https://indexed.vc/companies/venatorx-pharmaceuticals-inc"><img src="https://indexed.vc/api/badge/company/venatorx-pharmaceuticals-inc" alt="VENATORX PHARMACEUTICALS INC on Indexed.vc" width="260" height="76" /></a>